BioSig Technologies, Inc. (BSGM)
NASDAQ: BSGM · Real-Time Price · USD
1.040
+0.120 (13.04%)
At close: Apr 28, 2025, 4:00 PM
1.020
-0.020 (-1.92%)
After-hours: Apr 28, 2025, 5:03 PM EDT
Company Description
BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms.
It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines.
The company’s product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy.
The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system.
BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
BioSig Technologies, Inc.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Anthony Amato |
Contact Details
Address: 55 Greens Farms Road, 1st Floor Westport, Connecticut 06880 United States | |
| Phone | 203 409 5444 |
| Website | biosig.com |
Stock Details
| Ticker Symbol | BSGM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001530766 |
| CUSIP Number | 09073N201 |
| ISIN Number | US09073N3008 |
| Employer ID | 26-4333375 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Anthony Amato | Chief Executive Officer and Chairman |
| Ferdinand Groenewald | Interim Chief Financial Officer and Principal Accounting Officer |
| Dr. Budimir S. Drakulic Ph.D. | Chief Scientist |
| Lora Mikolaitis | Chief Administrative Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2025 | 8-K | Current Report |
| Apr 15, 2025 | 10-K | Annual Report |
| Mar 31, 2025 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 26, 2025 | D | Notice of Exempt Offering of Securities |
| Mar 25, 2025 | 8-K | Current Report |
| Mar 6, 2025 | 8-K | Current Report |
| Mar 5, 2025 | 8-K | Current Report |
| Mar 3, 2025 | 8-K | Current Report |
| Jan 13, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Dec 31, 2024 | 8-K | Current Report |